Authors of the PRAISE phase 2 trial evaluated whether a fully recombinant human monoclonal antibody against CTGF could slow, stop, or reverse the progression of idiopathic pulmonary fibrosis.
It is recommended that patients with COPD receive the annual influenza vaccination. Authors of a new study evaluated the vaccine’s effectiveness against laboratory-confirmed influenza-associated...
Despite the popularity of vaping, evidence on long-term pulmonary effects is limited. In a recent study, researchers explored the association between vaping and asthma risk in individuals who had never used...
Because less-invasive, nonsurgical approaches are needed to treat severe emphysema, authors of a new study compared the safety and efficacy of the Spiration Valve System with optimal medical management. ...
In an effort to find a shorter, more efficacious oral regimen to treat patients with drug-susceptible tuberculosis, authors of a new study analyzed the bactericidal activity and safety of several...
The Centers for Disease Control and Prevention has release two reports concerning vaping and e-cigarette, or vaping, product use–associated lung injury.
The ATS, CDC, ERS, and IDSA have developed practice guidelines that include 25 recommendations on the treatment of drug-resistant tuberculosis, including multidrug-resistant TB and isoniazid-resistant but...
Over the course of the OPTIMA trial, researchers evaluated the safety, efficacy, and tolerability of macitentan-tadalafil combination therapy among treatment-naïve adults who were newly diagnosed with...
Over the course of the OPTIMA trial, researchers evaluated the safety, efficacy, and tolerability of macitentan-tadalafil combination therapy among treatment-naïve adults who were newly diagnosed with...
